|
|
Books > Medicine > Other branches of medicine > Pharmacology > General
Volume 22, entitled Metal Ions in Bio-Imaging Techniques, of the
series Metal Ions in Life Sciences deals with metal ions as tools
in imaging. This dates back to the first half of the past century,
when barium sulfate was orally given to patients undergoing X-ray
examination. The use of contrast agents has since developed into a
large interdisciplinary field encompassing not only medicine, but
also chemistry, material sciences, physics, biology, engineering,
and computer sciences. MILS-22 provides deep and current insights
in 17 stimulating chapters on the new research frontiers of this
fast growing field on bio-imaging ... and beyond. For example,
adding bio-sensing yields theranostic agents, meaning diagnosis and
therapy linked in the same molecule; ions of Gd, Mn, Fe, Co, Ir,
99mTc, etc., are involved. Other important topics are, e.g., metal
complexes in paramagnetic Chemical Exchange Transfer (paraCEST),
radiometals for Positron Emission Tomography (PET) imaging, or
paramagnetic metal ion probes for 19F magnetic resonance imaging.
MILS-22 is written by 57 internationally recognized experts from 12
countries, that is, from the US via Europe to China. The impact of
this vibrant research area is manifested by more than 2300
references and nearly 120 figures, mostly in color, and several
informative tables. To conclude, Metal Ions in Bio-Imaging
Techniques is an essential resource for scientists working in the
wide range from material sciences, enzymology, analytic, organic,
and inorganic biochemistry all the way through to medicine
including the clinic ... not forgetting that also excellent
information for teaching is provided.
This book addresses chemical and biological aspects related to
sesquiterpene lactones (STLs). Experts in different fields have
been invited to contribute on this class of compound's chemistry,
isolation and identification, biological activities (antibacterial,
antifungal, antiviral, antitrypanosomal,
antileishmanial,antiplasmodial, antiproliferative and
antiinflammatory), synthesis, biosynthesis, derivatization and QSAR
analysis. Taxonomic and chemotaxonomic aspects related to the
Asteraceae family are also contributed. The book begins by
describing the chemical characteristics of STLs, their
classification in different skeleton types, synthesis, distribution
in nature and their most important biological properties. An
overview of the group's main representatives, based on their
importance for human health, as well as an update of the most
recently isolated STLs, follow. The authors also provide an
overview of the most common methods described in the literature for
the extraction, purification, identification and structure
elucidation of STLs, while also highlighting more recently
developed methods. Furthermore, experts in the field provide an
in-depth discussion of the most commonly employed in vitro and in
vivo antiprotozoal assays against the different stages of
parasites, as well as STLs' properties as anticancer agents in
numerous cancer cell lines and animal models. Lastly, the book
presents examples of the in vitro and in vivo activity of STLs and
their mechanism of antiprotozoal action, together with an analysis
of ultrastructural alterations, observed using TEM techniques. The
book is aimed at scientists working on natural products: both those
investigating this particular group of compounds and those who wish
to further explore its potential as new drugs for medical
conditions such as protozoal diseases and cancer.
This incisive book offers an epidemiological study of road users'
consumption of psychoactive substances in Nigeria. It examines
psychoactive drug screening and the use of driving simulators to
evaluate skills impairment after drinking alcoholic beverages.
Portable electronic digital screening devices such as "Oral
Screen," along with other screening devices were used to establish
the prevalence of substances of abuse amongst road users in some
selected cities in Nigeria. Blood, saliva, urine, and other
biological fluids were screened. Skills impairment, characterized
by unsafe driving actions based on the level of blood alcohol
concentration (BAC), was evaluated using a driving simulator. The
findings were validated by application of a Field Impairment Test
(FIT) or modified clinical test of impairment. The implication of
the results on everyday highway utilization and the best approach
for research into screening for psychoactive drugs are highlighted,
along with several recommendations to enhance highway safety.
Edeaghe Ehikhamenor is a senior lecturer at the University of
Benin, Benin City, Nigeria, and the founder/national coordinator of
Save Accident Victims Association of Nigeria (SAVAN)
(www.savan.org). He has a bachelor of dental surgery, (BDS) a
master's in pharmacology, and a Ph.D. in pharmacology and
toxicology from the University of Benin. He has extensive research
experience on digital screening of alcohol and other psychoactive
drugs with saliva and biological fluids to establish skills
impairment on a driving simulator. Hope Obianwu is a professor of
pharmacology and toxicology who has served as past dean of pharmacy
at the University of Benin and the department head at Niger Delta
University in Nigeria. He is on the editorial board of several
national and international journals, and has mentored several Ph.D.
and master's graduates in pharmacology. Publisher's website: http:
//sbprabooks.com/EdeagheEhikhamenorandHopeObianwu
Expanding from the classic use of immunosuppressants in
transplantation and rejection, this current overview highlights
their new roles in clinical medicine. Immunosuppressants are at the
forefront of new treatment modalities. Individual chapters focus on
their use not only in prevention or treatment of transplant
rejection, but also on their use in immune-complex and autoimmune
diseases, including rheumatoid arthritis; on combination therapies
to achieve synergy in immunosuppression; on new drugs, low
molecular weight chemicals, the use of antibodies and gene therapy;
on immunological tolerance to prevent or inhibit transplant
rejection; and how data derived from transplant studies can be
applied to other avenues of immunosuppression. Clinicians and
researchers will appreciate the scope of the work and the
presentation of new approaches in the rapidly developing field of
immunosuppression.
While millions of Americans receive vaccinations each year, a vocal
segment of the population is opposed to all immunizations—some
even refusing to get mandated vaccinations for their children. In
The Vaccine Controversy, Dr. Kurt Link—a specialist in internal
medicine—explores that paradox and provides a history of vaccine
development, including such possible future vaccines as those being
developed in the hope of immunizing against HIV. A strong supporter
of vaccination programs, Link explains the immune system and how it
works, as well as outlining the various types of vaccines
(including the efficacy and potential toxicity of each). Appendices
spell out current medical recommendations for vaccines, describe
the legal issues involved in decisions to vaccinate or not, and
explain the workings of clinical trials where work is done to
determine if a vaccine is effective or not, or has any remarkable
side effects. Millions of Americans are vaccinated each year,
whether they are elders looking to avoid bouts of influenza or
children whose parents want to protect them from potentially deadly
childhood diseases. Still, there remains a vocal segment of the
population in opposition to all immunization, some even refusing to
get mandated vaccinations for their children. Here, a specialist of
internal medicine explores that paradox. Dr. Link explains the
immune system and how it works, as well as the history of vaccine
development, and the various types of vaccines including the
efficacy and potential toxicity of each. A physician for more than
35 years, Link also spotlights possible future vaccines, such as
those being developed in the hope of immunizing against HIV.
Appendices to this work spell out current medical recommendations
for vaccines, describe the legal issues involved in decisions to
vaccinate or not, and explain the workings of clinical trials where
work is done to determine if a vaccine is effective or not, or has
any remarkable side effects. A strong supporter of vaccination
programs, Link says that all people should understand the powers,
limitations and risk of immunization.
This issue of Dental Clinics of North America focuses on
Pharmacology and Therapeutics for the Dentist. Articles will
include: Emergency Drugs for the Dental Office; Oral Sedation for
Adult and Pediatric Dental Patients; Update on Analgesic Medication
for Adult and Pediatric Dental Patients; Medication Management for
TMD/TMJ Dental Patients; Medications and their Role in the Chronic
Facial/Neuropathic Pain of Dental Patients; Medication Management
for Xerostomia and Glossodynia in the Dental Patient; Update on
Topical and Local Anesthesia Agents for Dental Patients; Current
Concepts of Prophylactic Antibiotics for Dental Patients;
Medication Management of Jaw Lesions for Dental Patients; Current
Update on Antibiotic Therapy for Odontogenic Infections in Dental
Patients; Review of Top 10 Prescribed Drugs and their Interaction
with Dental Treatment; Botox: Review and Its Role in the Dental
Office; Medication and the Gravid and Nursing Dental Patient;
Conscious IV Sedation in Dentistry: A Review of Current Therapy;
Medications to Assist in Tobacco Cessation for the Dental Patient;
Topical and Systemic Drugs in the Treatment of Oral Ulcers for the
Dental Patient, and more!
Rapid progress has been made in our understanding of the molecular
mechanisms of cell growth and oncogenesis during the past decade.
Special attention has been given to the presentation of the
frequently neglected close correlation between changes in signal
transduction and metabolic pathways during oncogenesis. This book
advances the knowledge of mechanisms regulating metabolism and
functioning of vitamin A and offers the most recent results of
research on the clinical efficiency of retinoids in skin disorders
and cancer. The book presents recent findings on the regulation of
cell growth in normal and neoplastic tissues by growth factors
including hormones, and by the activation and inactivation of
oncogenes and tumor suppressor genes, respectively. It also offers
a survey of the molecular and cell biochemistry of retinoids. Basic
researchers in biochemistry, pharmacology and cell biology as well
as clinicians will find this book very informative and up-to-date.
This book advances the knowledge of mechanisms regulating
metabolism and functioning of vitamin A and offers the most recent
results of research on clinical efficiency of retinoids in skin
disorders and cancer. Basic researchers in biochemistry,
pharmacology, cell biology, and clinicians will find this book very
informative and up-to-date. The chapters, organized in six
sections, are contributed by leading scientists who have been
working in the retinoid field for decades. Their experience and
competence is aknowledged worldwide.
This issue of the Clinics in Laboratory Medicine on
"Pharmacogenomics" is being edited by Drs. Roland Valdes and
Kristen Reynolds and will cover a wide variety of topics, including
but not limited to, fundamentals of pharmacology, a review of
pharmacogenetics guidelines, pharmacogenetic testing in pain
management, pharmacogenetics of pain management, clinical and
economic impact of pharmacogenetic genotyping analysis, exosome
analysis in lab medicine, and implementation of pharmacogenetics in
developing countries.
This book brings together mental health professionals and
researchers to offer the most up-to-date information on the
diagnosis, treatment, and research surrounding bipolar depression.
Its individual chapters provide valuable diagnostic information,
allowing clinicians to distinguish between the various mood
disorders. Further, they: review the course, outcome, and genetics
of this highly heritable condition; offer a thorough overview of
the neurobiology of the disorder, including what is known from
neuroimaging work; delineate the treatment of bipolar depression in
special populations such as children and pregnant women; address
suicide, focusing on the need for assessment during both acute and
maintenance treatment with interventions appropriate to a patient's
symptoms and history; and cover acute and long-term treatment
strategies for bipolar depression, including both traditional and
novel therapeutics for the disorder, as well as non-pharmacological
treatments. This second edition reflects significant advances,
including an improved understanding of the altered neurobiology of
patients suffering from bipolar depression, new information on
pathophysiology and genetic findings drawn from diverse studies,
and a discussion of the significant strides made towards improved
treatment with already available and novel agents.
Retinoids have received considerable attention in recent years and
due cognizance has been given to their versatility as biological
response modifiers, as evidenced by the virtually explosive growth
of literature in this field in the past few years. This volume has
been designed to give a current state-of-the-art picture of
retinoids. The perceived potential of retinoids in the treatment of
certain disease stated has initiated attempts at identifying and
synthesizing new retinoid derivatives with definable and selective
effects on aberrant biological phenomena. Appropriately, therefore,
we begin with the chemistry of retinoids and their derivatives
together with discussions of their biological activity. Major
advances have been made in understanding the mechanisms by which
retinoids modulate physiological and phenotypic traits of cells.
The transduction of retinoid signaling by the mediation of nuclear
receptors of the steroid/thyroid receptor superfamily has now been
studied extensively and the cloning and defining the
characteristics of these receptors has been a focus of discussion
in this volume. Retinoids also markedly modulate the transduction
of extracellular signals such as those imparted by growth factors
and hormones, and thus actively influence and control cellular
proliferative patterns. Retinoids can alter epidermal growth factor
receptor expression (Kawaguchi et al., 1994), responsiveness to
thyroid hormone (Esfandiari et al., 1994; Pallet et al., 1994),
inhibit the proliferative responses of hematopoietic progenitor
cells to granulocyte colony stimulating factor (Smeland et al.,
1994), and modulate secretion on interleukins by leukaemic cells
(Balitrand et al., 1994), among other things. This has obvious
implications for pharmacological manipulation of deregulated growth
(Dickens and Colletta, 1993; Mulshine et al., 1993). Apoptosis is
another component in the regulation of growth control. Apoptotic
cell death is influenced by several agents and retinoids may
function by interfering with apoptotic pathways of regulation of
growth control and quite legitimately, therefore, the importance of
this aspect of retinoid function has been duly recognized here.
This issue of Medical Clinics of North America, guest edited by
Drs. Douglas Paauw and Kim O'Connor, is devoted to Pharmacologic
Therapy. Articles in this issue include: Pharmacologic Therapies
for Autoimmune and Rheumatologic Conditions; Pharmacologic
Therapies for Ophthalmologic Conditions; Pharmacologic Therapies
for Neurologic Conditions; Pharmacologic Therapies for Cardiac
Conditions; Pharmacologic Therapies in Men's Health; Pharmacologic
Therapies in Anticoagulation; Pharmacologic Therapies in Women's
Health: Menopause Treatment and Contraception; Pharmacologic
Therapies in GI disease; Pharmacologic Therapies in Pulmonology and
Allergy; Pharmacologic Therapies for Substance Abuse; Pharmacologic
Therapies in Infectious Disease; Pharmacologic Therapies for HIV;
Pharmacologic Therapies in Type 2 DM; Pharmacologic Therapies in
Musculoskeletal Conditions; and Osteoporosis Treatment.
Corticosteroids represent the most important and frequently used
class of anti-inflammatory and immunosuppressant agents in the
management of many rheumatological conditions. Included in this
issue will be articles on the following topics: Glucocorticoid use
in intra-articular and soft tissue injections, corticosteroids and
osteoporosis, corticosteroids in lupus, ANCA associated vasculitis,
and many more!
This innovative text explores the cellular transport of organic
cations, from functional and structural properties to
pharmacological implications and psychiatric developments. The
authoritative chapters introduce organic cation transporters and
then proceed to discuss their mechanisms such as binding of
substrates and inhibitors; their drug dispositions and toxicity;
their relationships to genetic and pathophysiological variability;
and their roles in endocrine, metabolic, and neurological systems.
The final chapters delve into the use of animal models for the
study of organic cation transporter function and their possible use
in environmental cycling of pharmaceutical residues. This
comprehensive volume unites integrative transporter physiology with
structural and molecular biology, genetics, pharmacology and
pathophysiology, offering a holistic approach to utilizing this
novel technique in physiological contexts. It will prove invaluable
reading for researchers and students in various areas of
integrative, organ, cell and molecular physiology as well as
pharmacologists and neurologists.
|
|